AFW GER Week ended 24 Jul 2026

Weekly Investor Report

Align Technology, Inc. · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 148.9 EUR
-8.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is -1.1% below the Trend Line and sits at 17.6% of its 52-week range. The latest completed week returned -8.7%, after a 2.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 30 out of 100
Latest Close 148.9 EUR 24 Jul 2026
1W Return -8.7% latest completed week
4W Return 2.2% short-term follow-through
12W Return -0.6% quarterly tape
Trend Breadth 13.5% 7 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 7-week active streak.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 39.29% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -8.7% Latest completed week; four-week move 2.2%. Indicator stack 32/61 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 39.29% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 19 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is -1.1% below the Trend Line and sits at 17.6% of its 52-week range. The latest completed week returned -8.7%, after a 2.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
9 Jan 16 Jan 23 Jan 30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3212-week average 0.24

12-week confirmation

Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.32Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.2% over four weeks, -0.6% over 12 weeks, and -52.5% over one year. The current trend has remained active for 7 consecutive weeks.

Performance by holding period

1W-8.7%
4W2.2%
12W-0.6%
26W12.1%
52W-52.5%
Active trend streak7 weeks
Active weeks in one year7
Trend breadth13.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.26Latest activity-pressure read.
Pressure change74.8%Four-week change in activity pressure.
Leadership-28.83Latest relative-leadership reading.
RS change14.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 87%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength26/100Blend of value, momentum, and quality. Underlying universe rank 75; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality89/100Profitability and accounting quality. Underlying universe rank 12; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth28/100Revenue and earnings growth. Underlying universe rank 73; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework63/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
24.8x
Price divided by trailing earnings.
Price / sales
2.6x
Market value relative to trailing revenue.
EV / EBITDA
11.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
67.6%
Gross profit retained from each unit of revenue.
Operating margin
15.2%
Operating profit retained from revenue.
Free-cash-flow margin
14.2%
Free cash flow generated from revenue.
Return on invested capital
14.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
0.9%
Latest one-year revenue growth.
EPS growth
0.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-21.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
2.6%
Net share repurchases relative to market value.
Shareholder yield
2.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 19 relevant articles.

0 positive · 19 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-52.5%Distance below the 52-week high.
13-week volatility6.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2610 weeks finished lower.
Best week+14.7%Week of 13 Feb.
Worst week-14.2%Week of 22 May.
Latest week-8.7%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks4
Modest losses5
Sharp losses5
Recent vol6.1%13-week weekly-return volatility.
Base vol9.9%52-week weekly-return volatility.
Up/down split16/15Count of positive and negative weeks in the 52-week window.
Average skew5.6% / -8.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis50/100

Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.32; No reversal markers Next-Week ExpectancyNegative 39.29%

Next-week expectancy is negative with a 39.29% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors38/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 18; Small Cap Core rank 76 SVQF63/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 137.0 of 373 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 19 relevant articles.

Align Tech (AFW) Q1 2024 Earnings Report - Results, Call & Slides Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026148.9 EUR-8.7%150.6 EUR276.8 EUR0.26-28.8334On
17 Jul 2026163.1 EUR1.0%150.1 EUR277.8 EUR0.28-22.4749On
10 Jul 2026161.6 EUR8.4%148.9 EUR278.8 EUR0.16-25.050On
12 Jun 2026149.1 EUR2.3%147.6 EUR279.7 EUR0.01-30.720On
5 Jun 2026145.8 EUR-2.5%146.7 EUR280.6 EUR0.15-33.66102On
29 May 2026149.4 EUR6.6%145.6 EUR281.5 EUR0.29-33.9149On
22 May 2026140.1 EUR-14.2%151.1 EUR282.2 EUR0.42-38.4244On
15 May 2026163.3 EUR0.0%156.9 EUR283.0 EUR0.59-26.620Off
8 May 2026163.3 EUR0.0%161.9 EUR283.7 EUR0.64-28.730Off
1 May 2026163.3 EUR0.0%166.9 EUR284.5 EUR0.59-29.540Off
24 Apr 2026163.3 EUR0.0%171.9 EUR285.5 EUR0.52-30.030Off
17 Apr 2026163.3 EUR9.0%176.9 EUR286.5 EUR0.48-32.64190Off
10 Apr 2026149.8 EUR0.3%181.9 EUR287.6 EUR0.32-36.91157Off
3 Apr 2026149.4 EUR-4.3%187.4 EUR288.6 EUR0.28-36.4662Off
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.